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Abstract 
Aspergillus fumigatus is the most frequent agent of aspergilosis and reports on infections caused by this species or its siblings are becoming more frequent. The overall objective of the 
study is to understand the epidemiology of the Aspergillus isolates (species and antifungal resistance) collected in the Portuguese National Reference Laboratory through our surveillance 
system on Aspergillus. During the period 2013-2017, 117 Aspergillus section Fumigati isolates were collected from 15 healthcare institutions of all country, and from different 
environmental sources .These isolates were identified on the basis of macro and microscopic morphology and through the use of molecular tools. Surveillance of azole resistance was 
performed firstly azole-resistant screening media, broth microdilution method or PCR for detection of mutations in the Cyp51A gene (when applicable). From the isolates collected during 
the study period, 94 were from clinical (human) sources, 2 from animals diagnosed with aspergillosis and 21 from environmental sources. In total, 111 A. fumigatus sensu stricto isolates 
were identified, followed by 3 A. lentulus, 2 A. felis and 1 A. hiratsukae. Regarding susceptibility, relevant and residual growths were obtained in azole resistance screening media . The 
positive results were then screened by microdilution method and also by detection of Cyp51A mutations resistances were not confirmed.  The median MIC values were higher than what 
is described in other studies which may explain the growth in screening media and may suggest a local epidemiology.   
Introduction 
Aspergillus is one of the major fungal threats to 
immunocompromised patients, causing significant morbidity and 
mortality, especially of solid organ transplant patients or recipients 
of allogeneic haematopoietic stem cell transplantation. Aspergillus 
fumigatus is the most frequent agent of aspergilosis and reports on 
infections caused by this species or its siblings are becoming more 
frequent, together with the increasing number of at risk patients. 
Nowadays, due to the rising concerns on emerging antifungal 
resistance, the epidemiological surveillance for clinical and 
environmental isolates is mandatory.   
Objectives  
The overall objective of the project is to understand the 
epidemiology of the Aspergillus isolates (species and antifungal 
resistance) collected in the Portuguese National Reference 
Laboratory through our surveillance system on Aspergillus. 
Methods 
• During the period 2013-2017, 117 Aspergillus section Fumigati 
isolates were collected at the National Health Reference Dr. Ricardo 
Jorge, through the surveillance system on Aspergillus. 
 
• All isolates were identified on the basis of macro and microscopic 
morphology and through ITS and calmodulin sequencing  
 
• Surveillance of azole resistance was performed firstly using 
Sabouraud dextrose agar supplemented with itraconazole (ICZ), 
voriconazole (VCZ), and posaconazole (PCZ). When growth was 
observed, the minimal inhibitory concentration (MIC) was 
determined by broth microdilution method (CLSI M38A2). In case of 
doubt, a specific PCR for detection of mutations in the Cyp51A gene 
of A. fumigatus was performed using the AsperGenius® multiplex 
real-time PCR assay.  
Results  
• 94 isolates were from clinical (human) sources, 2 from animals diagnosed 
with aspergillosis and 21 from environmental sources (including hospital 
environment)  
 
• Clinical isolates were obtained from 90 patients (53 males, 34 females, 3 
not known), with ages ranging from 37 days to 88 years old. 98% of the 
isolates were from respiratory specimens. The underlying diseases reported 
are, among others, cystic fibrosis, COPD, HIV, asthma, and neoplasms. 
 
• In total, 117 A. fumigatus (sensu stricto and cryptic species) were identified 
(Table 1). In 7 cases, the morphological identification did not matched with 
the correct species-section. Interestingly, the 5 clinical cryptic species (A. 
lentulus and A. felis) were from the same hospital.  
Conclusions 
In our collection of Fumigati isolates, 5% of them were cryptic species. 
Although no azole resistance was found by microdilution or detection of 
Cyp51A mutations, the MIC values obtained suggest that the median values 
are higher than what is described in other studies (1.4 to ICZ, 0.4 to PCZ), 
which may explain the growth in screening media and may suggest a local 
epidemiology different from other countries.  
Species molecular identification  Number of collected isolates  Source 
Aspergillus fumigatus sensu stricto 111 Clinical and Environmental 
Aspergillus lentulus 3 Clinical (respiratory specimens) 
Aspergillus felis 2 Clinical (respiratory specimens) 
Aspergillus hiratsukae 1 Hospital environment 
ICZ (4 mg/mL)  VCZ (1 mg/mL)  PCZ (0.5 mg/mL)  
Isolate growth in culture Relevant  Residual  Negative Relevant  Residual  Negative Relevant  Residual  Negative 
A. fumigatus sensu stricto (N=104)* 13 18 73 0 1 103 3 3 98 
A. lentulus (N=3) 2 0 1 1 1 1 2 0 1 
A. felis (N=1) 1 0 0 1 0 0 2 0 0 
A. hiratsukae (N=1) 0 0 1 0 0 1 0 0 1 
• Regarding susceptibility, relevant and residual growth were obtained in 
azole resistance screening media (Table 2). Positive results were then tested 
by microdilution method and by detection of Cyp51A mutations. The 
reference method did not confirm resistances and no Cyp51A mutations 
were found. 
Table 2. Results of inoculation of the studied Fumigati isolates in Sabouraud dextrose agar supplemented with itraconazole 4 mg/mL (ICZ), 
voriconazole 1 mg/mL (VCZ), and posaconazole 0.5 mg/mL (PCZ). 
Table 1. Aspergillus section Fumigati isolated during the study period   
*The remaining isolates lost their viability and did not grow in the positive control 
Positive 
control 
ICZ 
VCZ PCZ 
Figure 2: Screening media used for detection of azole resistance:  Sabouraud dextrose agar 
supplemented with itraconazole 4 mg/mL (ICZ), voriconazole 1 mg/mL (VCZ), and 
posaconazole 0.5 mg/mL (PCZ). 
Figure 1: Aspergillus section Fumigati: (a) Aspergillus fumigatus sensu stricto; (b) Aspergillus lentulus; (c) Aspergillus felis  
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